Crescent Grove Advisors, LLC Bristol Myers Squibb CO Transaction History

Crescent Grove Advisors, LLC

  • $931 Million
  • Q1 2024

A detailed history of Crescent Grove Advisors, LLC transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Crescent Grove Advisors, LLC holds 10,875 shares of BMY stock, worth $435,652. This represents 0.06% of its overall portfolio holdings.

Number of Shares
10,875
Previous 11,825 8.03%
Holding current value
$435,652
Previous $606,000 2.81%
% of portfolio
0.06%
Previous 0.07%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 29, 2024
SELL
$47.98 - $54.4 $45,581 - $51,680
-950 Reduced 8.03%
10,875 $589,000
Q4 2023

Jan 30, 2024
BUY
$48.48 - $57.85 $53,085 - $63,345
1,095 Added 10.21%
11,825 $606,000
Q3 2023

Oct 25, 2023
SELL
$57.89 - $64.73 $341,145 - $381,453
-5,893 Reduced 35.45%
10,730 $622,000
Q2 2023

Jul 13, 2023
BUY
$63.71 - $70.74 $156,981 - $174,303
2,464 Added 17.4%
16,623 $1.06 Million
Q1 2023

May 03, 2023
SELL
$65.71 - $74.53 $105,398 - $119,546
-1,604 Reduced 10.18%
14,159 $981,000
Q4 2022

Jan 12, 2023
BUY
$68.48 - $81.09 $101,555 - $120,256
1,483 Added 10.39%
15,763 $0
Q3 2022

Nov 08, 2022
BUY
$0.13 - $76.84 $485 - $286,997
3,735 Added 35.42%
14,280 $1.02 Million
Q2 2022

Jul 20, 2022
SELL
$72.62 - $79.98 $450,244 - $495,876
-6,200 Reduced 37.03%
10,545 $818,000
Q1 2022

May 04, 2022
BUY
$61.48 - $73.72 $95,601 - $114,634
1,555 Added 10.24%
16,745 $1.23 Million
Q4 2021

Jan 24, 2022
BUY
$53.63 - $62.52 $302,741 - $352,925
5,645 Added 59.14%
15,190 $947,000
Q3 2021

Oct 26, 2021
SELL
$59.17 - $69.31 $213,012 - $249,516
-3,600 Reduced 27.39%
9,545 $569,000
Q2 2021

Jul 26, 2021
SELL
$61.91 - $67.42 $49,528 - $53,936
-800 Reduced 5.74%
13,145 $878,000
Q1 2021

May 07, 2021
SELL
$59.34 - $66.74 $11,868 - $13,347
-200 Reduced 1.41%
13,945 $887,000
Q4 2020

Feb 01, 2021
BUY
$57.74 - $65.43 $2,598 - $2,944
45 Added 0.32%
14,145 $884,000
Q3 2020

Nov 06, 2020
BUY
$57.43 - $63.64 $5,168 - $5,727
90 Added 0.64%
14,100 $850,000
Q2 2020

Aug 03, 2020
BUY
$54.82 - $64.09 $16,994 - $19,867
310 Added 2.26%
14,010 $824,000
Q4 2019

Feb 03, 2020
BUY
$49.21 - $64.19 $9,842 - $12,838
200 Added 1.48%
13,700 $879,000
Q2 2019

Aug 06, 2019
SELL
$44.62 - $49.34 $141,936 - $156,950
-3,181 Reduced 19.07%
13,500 $612,000
Q1 2019

May 13, 2019
BUY
$45.12 - $53.8 $1,082 - $1,291
24 Added 0.14%
16,681 $796,000
Q4 2018

Jan 29, 2019
BUY
$48.76 - $63.23 $48,760 - $63,230
1,000 Added 6.39%
16,657 $866,000
Q2 2018

Jul 16, 2018
BUY
$50.53 - $62.98 $50,530 - $62,980
1,000 Added 6.82%
15,657 $866,000
Q4 2017

Feb 06, 2018
SELL
$59.94 - $65.35 $17,982 - $19,605
-300 Reduced 2.01%
14,657 $898,000
Q3 2017

Nov 06, 2017
BUY
$55.23 - $63.74 $826,075 - $953,359
14,957
14,957 $953,000

Others Institutions Holding BMY

# of Institutions
2,553
Shares Held
1.49B
Call Options Held
25.9M
Put Options Held
20M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $85.2B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Crescent Grove Advisors, LLC Portfolio

Follow Crescent Grove Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Crescent Grove Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Crescent Grove Advisors, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email